Zobrazeno 1 - 10
of 232
pro vyhledávání: '"Paul C. Ho"'
Publikováno v:
Asian Journal of Pharmaceutical Sciences, Vol 13, Iss 1, Pp 72-81 (2018)
Epilepsy is considered as a common and diverse set of chronic neurological disorders and its symptoms can be controlled by antiepileptic drugs (AEDs). The presence of p-glycoprotein and multi-drug resistance transporters in the blood-brain barrier co
Externí odkaz:
https://doaj.org/article/00c0f4dbc67b4f8babb07f106efff04f
Autor:
Shanshan Liu, Paul C. Ho
Publikováno v:
Asian Journal of Pharmaceutical Sciences, Vol 12, Iss 4, Pp 378-385 (2017)
The aim of this paper is to investigate and optimize the preparation of scutellarin (SCU)-loaded HP-β-CD/chitosan (CS) nanoparticles (CD/CS-SCU-NPs). CD/CS-SCU-NPs were prepared by ionic cross-linking method and the process and formulation variables
Externí odkaz:
https://doaj.org/article/67eaa3abdb4e472888ba906450f1d354
Publikováno v:
Journal of Functional Foods, Vol 11, Iss , Pp 352-362 (2014)
This study aimed to evaluate the suitability of pterostilbene for anti-inflammatory application. The in vitro anti-inflammatory activities of pterostilbene were assessed using resveratrol, piceatannol and resveratrol trimethyl ether as comparators wh
Externí odkaz:
https://doaj.org/article/a9212240eba841ec96a14a5a96e4b354
Autor:
Ling-Zhi Wang, Jacqueline Ramírez, Winnie Yeo, Mei-Yi Michelle Chan, Win-Lwin Thuya, Jie-Ying Amelia Lau, Seow-Ching Wan, Andrea Li-Ann Wong, Ying-Kiat Zee, Robert Lim, Soo-Chin Lee, Paul C. Ho, How-Sung Lee, Anthony Chan, Sherry Ansher, Mark J. Ratain, Boon-Cher Goh
Publikováno v:
PLoS ONE, Vol 9, Iss 1 (2014)
Externí odkaz:
https://doaj.org/article/8a7ac3ddbc384872814137a589a51312
Autor:
Andrea Li Ann Wong, Arul Goel, Gautam Sethi, Lingzhi Wang, Xiaoqiang Xiang, Paul C. Ho, Pei Shi Ong, Ling-Wen Ding, Boon Cher Goh, Hannah Ying Lim
Publikováno v:
Cancer Letters. 521:252-267
Cancer is one of the world's biggest healthcare burdens and despite the current advancements made in treatment plans, the outcomes for oncology patients have yet to reach their full potential. Hence, there is a pressing need to develop novel anti-can
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 13; Pages: 7083
The immediate and delayed metabolic changes in rats treated with valproate (VPA), a drug used for the treatment of epilepsy, were profiled. An established approach using dried blood spots (DBS) as sample matrices for gas chromatography/mass spectrome
Publikováno v:
Molecular Pharmaceutics. 17:4256-4269
Curcumin (CUR) has antioxidant and anti-inflammatory effects that are beneficial to Alzheimer's disease (AD). However, the poor solubility and high instability of CUR compromise its application greatly. In this study, CUR-encapsulated chitosan-coated
Autor:
Daniel J F M Thuijs, A Pieter Kappetein, Patrick W Serruys, Friedrich-Wilhelm Mohr, Marie-Claude Morice, Michael J Mack, David R Holmes, Nick Curzen, Piroze Davierwala, Thilo Noack, Milan Milojevic, Keith D Dawkins, Bruno R da Costa, Peter Jüni, Stuart J Head, Filip Casselman, Bernard de Bruyne, Evald Høj Christiansen, Juan M. Ruiz-Nodar, Paul Vermeersch, Werner Schultz, Manel Sabaté, Giulio Guagliumi, Herko Grubitzsch, Karl Stangl, Olivier Darremont, M. Bentala, Peter den Heijer, Istvan Preda, Robert Stoler, Michael J. Mack, Tamás Szerafin, John K. Buckner, Myles S. Guber, Niels Verberkmoes, Ferdi Akca, Ted Feldman, Friedhelm Beyersdorf, Benny Drieghe, Keith Oldroyd, Geoff Berg, Anders Jeppsson, Kimberly Barber, Kevin Wolschleger, John Heiser, Pim van der Harst, Massimo A. Mariani, Hermann Reichenspurner, Christoffer Stark, Mika Laine, Paul C. Ho, John C. Chen, Richard Zelman, Phillip A. Horwitz, Andrzej Bochenek, Agata Krauze, Christina Grothusen, Dariusz Dudek, George Heyrich, Philippe Kolh, Victor LeGrand, Pedro Coelho, Stephan Ensminger, Boris Nasseri, Richard Ingemansson, Goran Olivecrona, Javier Escaned, Reddy Guera, Sergio Berti, Alaide Chieffo, Nicholas Burke, Michael Mooney, Alvise Spolaor, Christian Hagl, Michael Näbauer, Maarten Jan Suttorp, Ronald A. Stine, Thomas McGarry, Scott Lucas, Knut Endresen, Andrew Taussig, Kevin Accola, Umberto Canosi, Ivan Horvath, Louis Cannon, John D. Talbott, Chris W. Akins, Robert Kramer, Michael Aschermann, William Killinger, Inga Narbute, David R. Holmes, Francesco Burzotta, Ad Bogers, Felix Zijlstra, Helene Eltchaninoff, Jacques Berland, Giulio Stefanini, Ignacio Cruz Gonzalez, Uta Hoppe, Stefan Kiesz, Bartlomiej Gora, Anders Ahlsson, Matthias Corbascio, Thomas Bilfinger, Didier Carrie, Didier Tchétché, Karl-Eugen Hauptman, Elisabeth Stahle, Stefan James, Sigrid Sandner, Günther Laufer, Irene Lang, Adam Witkowski, Vinod Thourani, Harry Suryapranata, Simon Redwood, Charles Knight, Philip MacCarthy, Adam de Belder, Adrian Banning, Anthony Gershlick
Publikováno v:
The Lancet (London), 394, 1325-1334
Lancet (UK), 394(10206), 1325-1334. Elsevier Ltd.
The Lancet (London), 394, 10206, pp. 1325-1334
Lancet (UK), 394(10206), 1325-1334. Elsevier Ltd.
The Lancet (London), 394, 10206, pp. 1325-1334
Item does not contain fulltext BACKGROUND: The Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial was a non-inferiority trial that compared percutaneous coronary intervention (PCI) using first-generation paclitaxel-eluting stents with
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 4
International Journal of Molecular Sciences, Vol 22, Iss 2143, p 2143 (2021)
Volume 22
Issue 4
International Journal of Molecular Sciences, Vol 22, Iss 2143, p 2143 (2021)
Hair follicle morphogenesis is heavily dependent on reciprocal, sequential, and epithelial-mesenchymal interaction (EMI) between epidermal stem cells and the specialized cells of the underlying mesenchyme, which aggregate to form the dermal condensat
Autor:
Boxu Ren, Zhaowu Ma, Ling-Wen Ding, Paul C. Ho, Xiaoqiang Xiang, Marabeth Xin-Yi Kwah, Lingzhi Wang, Muthu K. Shanmugam, Cuiliu Liu, Pei Shi Ong, Boon Cher Goh
Publikováno v:
Cancer letters. 515
Resveratrol (3,4',5-trihydroxy-trans-stilbene) has been expected to ameliorate cancer and foster breakthroughs in cancer therapy. Despite thousands of preclinical studies on the anticancer activity of resveratrol, little progress has been made in tra